Description: Sight Sciences, Inc., an ophthalmic medical device company, engages the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. The company's products include OMNI Surgical System, a therapeutic device used by ophthalmic surgeons to reduce intraocular pressure in adult glaucoma patients; and TearCare System, a wearable eyelid technology, for the treatment of dry eye disease (DED) for ophthalmologists and optometrists. It offers products through sales representatives and distributors to hospitals, medical centers, and eyecare professionals in the United States. The company was incorporated in 2010 and is headquartered in Menlo Park, California.
Home Page: www.sightsciences.com
SGHT Technical Analysis
4040 Campbell Avenue
Menlo Park,
CA
94025
United States
Phone:
877 266 1144
Officers
| Name | Title |
|---|---|
| Mr. Paul Badawi | Co-Founder, Pres, CEO & Director |
| Dr. David Badawi M.D. | Founder, CTO & Director |
| Mr. Jesse Selnick | Chief Financial Officer |
| Mr. Sam Boong Park | Chief Operating Officer |
| Mr. John Ordway | VP of Manufacturing and Operations |
| Mr. Jeremy B. Hayden | Chief Legal Officer & Chief Compliance Officer |
| Mr. Aaron Capsel B.S., M.B.A. | VP of Sales & Bus. Operations |
| Ms. Stacie Rodgers | VP of HR |
| Dr. Reay H. Brown | Chief Medical Officer |
| Mr. John Liu | Sr. VP of Global Market Access |
Exchange: NASDAQ
Country: US
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 3.3746 |
| Price-to-Sales TTM: | 9.8107 |
| IPO Date: | 2021-07-15 |
| Fiscal Year End: | December |
| Full Time Employees: | 212 |